138 related articles for article (PubMed ID: 38159467)
21. Role and effectiveness of progestins in pituitary suppression during ovarian stimulation for assisted reproductive technology: a systematic review and a meta-analysis.
Yildiz S; Turkgeldi E; Ata B
Minerva Obstet Gynecol; 2023 Dec; 75(6):573-582. PubMed ID: 36193835
[TBL] [Abstract][Full Text] [Related]
22. Oocyte competence is comparable between progestin primed ovarian stimulation with Norethisterone acetate (NETA-PPOS) and GnRH-antagonist protocols: A matched case-control study in PGT-A cycles.
Vaiarelli A; Cimadomo D; Ruffa A; Rania E; Pittana E; Gallo C; Fiorenza A; Alviggi E; Alfano S; Carmelo R; Trabucco E; Alviggi C; Rosaria Campitiello M; Rienzi L; Maria Ubaldi F; Venturella R
Eur J Obstet Gynecol Reprod Biol; 2024 Mar; 294():4-10. PubMed ID: 38171151
[TBL] [Abstract][Full Text] [Related]
23. Progestin-primed ovarian stimulation protocol with or without letrozole for patients with normal ovarian reserve: a retrospective cohort study.
Jiang X; Jiang S; Diao H; Deng K; Zhang C
J Clin Pharm Ther; 2022 Apr; 47(4):469-476. PubMed ID: 34796515
[TBL] [Abstract][Full Text] [Related]
24. Should the trigger to oocyte retrieval interval be different in progestin-primed ovarian stimulation cycles?
Ata B; Cakar A; Türkgeldi E; Yildiz S; Keles İ; Kalafat E
Reprod Biomed Online; 2024 Feb; 48(2):103626. PubMed ID: 38160486
[TBL] [Abstract][Full Text] [Related]
25. Progestin-Primed Ovarian Stimulation Protocol for Patients in Assisted Reproductive Technology: A Meta-Analysis of Randomized Controlled Trials.
Guan S; Feng Y; Huang Y; Huang J
Front Endocrinol (Lausanne); 2021; 12():702558. PubMed ID: 34531825
[TBL] [Abstract][Full Text] [Related]
26. Analysis of euploidy rates in preimplantation genetic testing for aneuploidy cycles with progestin-primed versus GnRH agonist/antagonist protocol.
Wang L; Wang J; Zhang Y; Qian C; Wang X; Bai J; Li F; Chen Z; Ai A
Eur J Med Res; 2023 Jan; 28(1):28. PubMed ID: 36642707
[TBL] [Abstract][Full Text] [Related]
27. Letrozole cotreatment progestin-primed ovarian stimulation in women undergoing controlled ovarian stimulation for in vitro fertilization.
Wang X; Zhang Y; Diao H; Jiang S; Zhang C
J Obstet Gynaecol Res; 2024 May; 50(5):890-898. PubMed ID: 38403851
[TBL] [Abstract][Full Text] [Related]
28. Progestin-Primed Ovarian Stimulation Versus Mild Stimulation Protocol in Advanced Age Women With Diminished Ovarian Reserve Undergoing Their First
Tu X; You B; Jing M; Lin C; Zhang R
Front Endocrinol (Lausanne); 2021; 12():801026. PubMed ID: 35140685
[TBL] [Abstract][Full Text] [Related]
29. Effect of pretreatment with oral contraceptives and progestins on IVF outcomes in women with polycystic ovary syndrome.
Wei D; Shi Y; Li J; Wang Z; Zhang L; Sun Y; Zhou H; Xu Y; Wu C; Liu L; Wu Q; Zhuang L; Du Y; Li W; Zhang H; Legro RS; Chen ZJ
Hum Reprod; 2017 Feb; 32(2):354-361. PubMed ID: 27999118
[TBL] [Abstract][Full Text] [Related]
30. Outcomes of a GnRH Agonist Trigger Following a GnRH Antagonist or Flexible Progestin-Primed Ovarian Stimulation Cycle.
Kalafat E; Turkgeldi E; Yıldız S; Dizdar M; Keles I; Ata B
Front Endocrinol (Lausanne); 2022; 13():837880. PubMed ID: 35663329
[TBL] [Abstract][Full Text] [Related]
31. Ovarian stimulation for freeze-all IVF cycles: a systematic review.
Mizrachi Y; Horowitz E; Farhi J; Raziel A; Weissman A
Hum Reprod Update; 2020 Jan; 26(1):118-135. PubMed ID: 31867625
[TBL] [Abstract][Full Text] [Related]
32. Non-inferiority of progestin-primed ovarian stimulation versus GnRH antagonist protocol: A propensity score-weighted analysis.
Duc Thang L; Bao Long H; Thi Thu Trang D; Ngoc Quy P; Thi Mai Phuong G; Thi Hanh B; Trong Thach T; Thi Lien Huong N; Hoang L; Hugues JN
J Formos Med Assoc; 2024 Apr; 123(4):523-529. PubMed ID: 38092654
[TBL] [Abstract][Full Text] [Related]
33. Ovulation induction with high progesterone levels may be more suitable for elderly patients with low ovarian response.
Mu Z; Sa Y; Sun Z; Yi Y
J Gynecol Obstet Hum Reprod; 2021 Feb; 50(2):101661. PubMed ID: 31809957
[TBL] [Abstract][Full Text] [Related]
34. Comparison of euploidy rates of blastocysts in women treated with progestins or GnRH antagonist to prevent the luteinizing hormone surge during ovarian stimulation.
La Marca A; Capuzzo M; Sacchi S; Imbrogno MG; Spinella F; Varricchio MT; Minasi MG; Greco P; Fiorentino F; Greco E
Hum Reprod; 2020 Jun; 35(6):1325-1331. PubMed ID: 32395749
[TBL] [Abstract][Full Text] [Related]
35. Progestin primed ovarian stimulation using corifollitropin alfa in PCOS women effectively prevents LH surge and reduces injection burden compared to GnRH antagonist protocol.
Huang TC; Huang MZ; Seow KM; Yang IJ; Pan SP; Chen MJ; Hwang JL; Chen SU
Sci Rep; 2021 Nov; 11(1):22732. PubMed ID: 34815477
[TBL] [Abstract][Full Text] [Related]
36. Comparing blastocyst euploid rates between the progestin-primed and gonadotrophin-releasing hormone antagonist protocols in aneuploidy genetic testing: a randomised trial protocol.
Li H; Yu M; Zhang W; Chen J; Chen H; Lu X; Li L; Ng EHY; Sun X
BMJ Open; 2024 Mar; 14(3):e079208. PubMed ID: 38521533
[TBL] [Abstract][Full Text] [Related]
37. Fertility outcomes in women after controlled ovarian stimulation with gonadotropin releasing hormone agonist long protocol: fresh versus frozen embryo transfer.
Ding X; Yang J; Li L; Yang N; Lan L; Huang G; Ye H
BMC Pregnancy Childbirth; 2021 Mar; 21(1):207. PubMed ID: 33711956
[TBL] [Abstract][Full Text] [Related]
38. New trial of progestin-primed ovarian stimulation using dydrogesterone versus a typical GnRH antagonist regimen in assisted reproductive technology.
Iwami N; Kawamata M; Ozawa N; Yamamoto T; Watanabe E; Moriwaka O; Kamiya H
Arch Gynecol Obstet; 2018 Sep; 298(3):663-671. PubMed ID: 30069600
[TBL] [Abstract][Full Text] [Related]
39. Progestin-primed ovarian stimulation vs mild stimulation in women with advanced age above 40: a retrospective cohort study.
Peng Q; Cao X; Wang J; Wang L; Xu J; Ji X; Liu S; Zhu J; Dong X
Reprod Biol Endocrinol; 2019 Nov; 17(1):91. PubMed ID: 31706340
[TBL] [Abstract][Full Text] [Related]
40. Analysis of cumulative live birth rate and perinatal outcomes in young patients with low anti-müllerian hormone levels using two ovulation promotion protocols: A cohort study.
Li Z; Jia R; Wang K; Zhang J; Ren B; Guan Y
Front Endocrinol (Lausanne); 2022; 13():938500. PubMed ID: 35992097
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
